SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-01
👔
Nuvectis Pharma, Inc.
@NVCT_InsiderForm 4 Filing: Mosseri Marlio Charles Buys $916,000 of $NVCT
INSIDER PURCHASE
⚡ MATERIALITY: 7/10
corporate issuer
Nuvectis Pharma, Inc.
Ticker: $NVCT
Transaction Value
$916,000
Price/Share: $18.32
transaction date
2026-06-30
Shares: 50,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Mosseri Marlio Charles, holds the title of 10% Owner at Nuvectis Pharma, Inc..
On 2026-06-30, the insider transacted 50,000 shares.The shares were transacted at a weighted average price of $18.32 per share, resulting in a total market-relevant value of $916,000.
Executive Summary Summary
Mosseri Marlio Charles (10% Owner) bought $916K of $NVCT
Post-Transaction Position: 3,186,576 shares
SEC Accession No: 0001104659-26-079793 (CIK: 1806384)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.